GW-59884A

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NameGW-59884A
Drug Alias NameN/A
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionNeuropeptide Y receptor type 5 antagonists
TargetsNeuropeptide Y receptor type 5
Therapy Area/IndicationsObesity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGlaxosmithkline Plc
Active IndicationsN/A
Inactive IndicationsObesity

Other Information

ATC CodeN/A
Related LinksN/A